Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/1995
09/13/1995EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same
09/12/1995US5449766 DNA encoding NEI and NGE peptides
09/12/1995US5449752 Polypeptides with affinity to lipopolysaccharides and their uses
09/12/1995US5449750 Cyclic peptide enzyme inhibitors
09/12/1995US5449720 Amplification of the VB12 uptake system using polymers
09/12/1995US5449662 Atrial natriuretic peptide clearance inhibitors which resist degradation
09/12/1995US5449661 Angiotensin converting enzyme inhibitor and method for preparing same
09/12/1995CA1336954C Treatment of autoimmune diseases by oral administration of autoantigens
09/08/1995WO1995023811A1 Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
09/08/1995WO1995023612A1 Quantitation of individual protein kinase activity
09/08/1995WO1995023610A1 Pharmaceutical composition containing thymoctonan and azt
09/08/1995CA2160248A1 Pharmaceutical composition containing thymoctonan and azt
09/06/1995EP0670332A2 Protein complexes having factor VIII:C activity and production thereof
09/06/1995EP0669979A1 C-c ckr-1, c-c chemokine receptor
09/06/1995EP0669939A1 Somatotropin modifications
09/06/1995EP0669938A1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION
09/06/1995EP0669937A1 Peptide inhibitors of fibronectin and related collagen-binding proteins
09/06/1995EP0529075B1 Hybrid calcitonin
09/06/1995CN1029684C Process for preparing dynophine derivative
09/05/1995US5447915 Terminally blocked antiviral peptides
09/05/1995US5447914 Bactericides, fungicides
09/05/1995US5447854 Production of cyclosporin A and/or C with a strain of NECTRIA
08/1995
08/31/1995WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof
08/31/1995WO1995023166A1 Synthetic inverso or retro-inverso t-cell epitopes
08/31/1995WO1995023163A1 Pna combinatorial libraries and improved methods of synthesis
08/31/1995WO1995023159A1 Novel bombesin-related peptides
08/31/1995WO1995022996A2 Peptide-chelator conjugates
08/31/1995WO1995022991A2 Block copolymers
08/31/1995CA2183977A1 Synthetic inverso or retro-inverso t-cell epitopes
08/31/1995CA2183766A1 Block copolymers
08/31/1995CA2183556A1 Novel bombesin-related peptides
08/31/1995CA2182670A1 Peptide-chelator conjugates
08/30/1995EP0669001A1 Determination of peptide motifs on mhc molecules.
08/30/1995EP0668874A1 Lhrh antagonists and intermediate products
08/30/1995EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions
08/30/1995EP0668870A1 Inhibitors of picornavirus proteases
08/30/1995EP0668778A1 IMMUNIZATION AGAINST $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS)
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446023 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
08/29/1995US5446022 Cyclic polypeptides; protozoicides and fungicides;
08/29/1995US5445934 Selective photoremovable groups on surface
08/29/1995US5445832 Composition of sustained and controlled release of medicamentous peptide substances by converting water soluble peptide into a water insoluble peptide salt
08/29/1995US5445820 Streptolysin O peptide antigens and methods for the determination of streptolysin antibodies
08/29/1995US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use
08/29/1995CA1336827C 8-hydroxyquinoline chelating agents
08/24/1995WO1995022559A1 Immunosuppressive compounds and method of preparing same
08/24/1995WO1995022558A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
08/24/1995WO1995022346A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/24/1995WO1995022341A1 Labelled peptide compounds
08/24/1995WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995WO1995022338A1 Broad spectrum antimicrobial compounds and methods of use
08/24/1995CA2183421A1 Labelled peptide compounds
08/24/1995CA2183333A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
08/24/1995CA2183157A1 Immunosuppressive compounds and method of preparing same
08/24/1995CA2181827A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995CA2160251A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/23/1995EP0668290A1 Physiologically active substance well capable of permeating biomembrane
08/23/1995EP0667897A1 Method for specific immunoassay of human plasmatic glutathione peroxidase
08/23/1995EP0667871A1 Biologically active amphiphilic peptide compositions and uses therefor
08/23/1995EP0667786A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues
08/23/1995CN1107159A Linear adhesion inhibitors
08/22/1995US5444048 Antiinflammatory agents, analgesics
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443816 Peptide-metal ion pharmaceutical preparation and method
08/22/1995US5443815 Technetium-99m labeled peptides for imaging
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021861A1 Fk-506 cytosolic binding protein
08/17/1995WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2181803A1 Fk-506 cytosolic binding protein
08/16/1995EP0666920A1 Thrombin activatable plasminogen derivatives
08/16/1995EP0666867A1 Reagents and methods for treating rheumatoid arthritis
08/16/1995EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
08/16/1995EP0666754A1 Synthetic lung surfactant having antioxidant properties
08/16/1995EP0605410B1 Immunodiagnostic assay for rheumatoid arthritis
08/16/1995EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides
08/16/1995EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases
08/15/1995US5441936 Treatment of herpes simplex
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995CA2142394A1 Organic compounds
08/15/1995CA1336738C Intermediates produced during the preparation of new thymopentin retroinverso analogs
08/15/1995CA1336689C Determining cereal quality
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021194A1 Superactive vip antagonists
08/10/1995WO1995021193A1 Nerve growth factor structural analogs and their uses
08/10/1995WO1995021187A1 Cyclic neurokinin a antagonists
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995DE4404002A1 New thiazolyl-peptide derivs.
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/09/1995EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens
08/09/1995EP0665754A1 Antimicrobial peptides
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995EP0365525B1 Lymphocyte inhibition by hla peptides
08/08/1995US5440016 Peptides of the formula (KFmoc) ZZZ and their uses
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 423